Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q416073> ?p ?o }
Showing triples 1 to 65 of
65
with 100 triples per page.
- Q416073 subject Q21804508.
- Q416073 subject Q6442932.
- Q416073 subject Q7486806.
- Q416073 subject Q8662720.
- Q416073 subject Q8949762.
- Q416073 subject Q9052781.
- Q416073 abstract "Rifaximin (trade names:RCIFAX, Rifagut, Xifaxan, Zaxine) is a semisynthetic antibiotic based on rifamycin. It has poor oral bioavailability, meaning that very little of the drug will be absorbed into the blood stream when it is taken orally. Rifaximin is used in the treatment of traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy, for which it received orphan drug status from the U.S. Food and Drug Administration in 1998.".
- Q416073 atcPrefix "A07".
- Q416073 atcSuffix "AA11".
- Q416073 casNumber "80621-81-4".
- Q416073 chEBI "75246".
- Q416073 drugbank "DB01220".
- Q416073 fdaUniiCode "L36O5T016N".
- Q416073 iupacName "(2S,16Z,18E,20S,21S,22R,23R,24R,25S,26S,27S,28E)-5,6,21,23,25-pentahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-2,7-(epoxypentadeca-[1,11,13]trienimino)benzofuro".
- Q416073 iupacName "[4,5-e]pyrido[1,2-a]-benzimida-zole-1,15(2H)-dione,25-acetate".
- Q416073 pubchem "6436173".
- Q416073 thumbnail Rifaximin.svg?width=300.
- Q416073 wikiPageExternalLink 021361s009lbl.pdf.
- Q416073 wikiPageExternalLink xifaxan200.
- Q416073 wikiPageWikiLink Q12187.
- Q416073 wikiPageWikiLink Q1271831.
- Q416073 wikiPageWikiLink Q131029.
- Q416073 wikiPageWikiLink Q1367466.
- Q416073 wikiPageWikiLink Q138885.
- Q416073 wikiPageWikiLink Q147778.
- Q416073 wikiPageWikiLink Q150839.
- Q416073 wikiPageWikiLink Q1640868.
- Q416073 wikiPageWikiLink Q177900.
- Q416073 wikiPageWikiLink Q178436.
- Q416073 wikiPageWikiLink Q204711.
- Q416073 wikiPageWikiLink Q21804508.
- Q416073 wikiPageWikiLink Q25419.
- Q416073 wikiPageWikiLink Q265488.
- Q416073 wikiPageWikiLink Q272631.
- Q416073 wikiPageWikiLink Q380775.
- Q416073 wikiPageWikiLink Q388565.
- Q416073 wikiPageWikiLink Q422689.
- Q416073 wikiPageWikiLink Q45959.
- Q416073 wikiPageWikiLink Q461809.
- Q416073 wikiPageWikiLink Q642548.
- Q416073 wikiPageWikiLink Q6442932.
- Q416073 wikiPageWikiLink Q7486806.
- Q416073 wikiPageWikiLink Q831530.
- Q416073 wikiPageWikiLink Q838966.
- Q416073 wikiPageWikiLink Q8662720.
- Q416073 wikiPageWikiLink Q8949762.
- Q416073 wikiPageWikiLink Q9052781.
- Q416073 wikiPageWikiLink Q9368.
- Q416073 atcPrefix "A07".
- Q416073 atcSuffix "AA11".
- Q416073 casNumber "80621".
- Q416073 chebi "75246".
- Q416073 drugbank "DB01220".
- Q416073 iupacName "-56212325".
- Q416073 iupacName "[4,5-e]pyrido[1,2-a]-benzimida-zole-1,15-dione,25-acetate".
- Q416073 pubchem "6436173".
- Q416073 unii "L36O5T016N".
- Q416073 type ChemicalSubstance.
- Q416073 type Drug.
- Q416073 type ChemicalObject.
- Q416073 type Thing.
- Q416073 type Q8386.
- Q416073 comment "Rifaximin (trade names:RCIFAX, Rifagut, Xifaxan, Zaxine) is a semisynthetic antibiotic based on rifamycin. It has poor oral bioavailability, meaning that very little of the drug will be absorbed into the blood stream when it is taken orally. Rifaximin is used in the treatment of traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy, for which it received orphan drug status from the U.S. Food and Drug Administration in 1998.".
- Q416073 label "Rifaximin".
- Q416073 depiction Rifaximin.svg.